How Healthcare M&A Firms Handle Antitrust and Regulatory Scrutiny in Consolidation
How Healthcare M&A Firms Handle Antitrust and Regulatory Scrutiny in Consolidation Key Takeaways Understanding the Regulatory Landscape in Healthcare M&A Healthcare mergers and acquisitions (M&A) have grown in complexity as regulators tighten oversight. Agencies like the Federal Trade Commission (FTC) and the Department of Justice (DOJ) actively monitor transactions to prevent monopolies and protect patient […]
Read More
When a Healthcare CEO Should Switch Advisors Mid-Process (Red Flags & Timing)
When a Healthcare CEO Should Switch Advisors Mid-Process (Red Flags & Timing) Key Takeaways Introduction Selling or merging a healthcare organization is one of the most complex financial decisions a CEO will ever make. Unlike routine operational choices, M&A transactions impact legacy, staff stability, patient continuity, and long-term wealth. Yet many healthcare leaders hesitate to […]
Read More
Managing Multi-Stakeholder Complexity Without Losing Strategic Momentum
Managing Multi-Stakeholder Complexity Without Losing Strategic Momentum Key Takeaways Understanding Multi-Stakeholder Complexity in Healthcare M&A In today’s healthcare landscape, mergers and acquisitions are rarely simple. Unlike traditional business deals, healthcare M&A involves multiple stakeholders—investors, hospital administrators, physicians, private equity firms, DSOs, MSOs, and even regulatory bodies. Each of these groups has its own priorities, interests, […]
Read More